Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

MyNCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2006 21
2007 44
2008 55
2009 40
2010 36
2011 39
2012 30
2013 32
2014 24
2015 34
2016 26
2017 15
2018 20
2019 13
2020 0
Text availability
Article attribute
Article type
Publication date

Search Results

364 results
Results by year
Filters applied: . Clear all
Page 1
Low-dose colchicine for secondary prevention of cardiovascular disease.
Nidorf SM, Eikelboom JW, Budgeon CA, Thompson PL. Nidorf SM, et al. J Am Coll Cardiol. 2013 Jan 29;61(4):404-410. doi: 10.1016/j.jacc.2012.10.027. Epub 2012 Dec 19. J Am Coll Cardiol. 2013. PMID: 23265346 Free article. Clinical Trial.
A polymer-coated, paclitaxel-eluting stent (Eluvia) versus a polymer-free, paclitaxel-coated stent (Zilver PTX) for endovascular femoropopliteal intervention (IMPERIAL): a randomised, non-inferiority trial.
Gray WA, Keirse K, Soga Y, Benko A, Babaev A, Yokoi Y, Schroeder H, Prem JT, Holden A, Popma J, Jaff MR, Diaz-Cartelle J, Müller-Hülsbeck S; IMPERIAL investigators. Gray WA, et al. Lancet. 2018 Oct 27;392(10157):1541-1551. doi: 10.1016/S0140-6736(18)32262-1. Epub 2018 Sep 24. Lancet. 2018. PMID: 30262332 Clinical Trial.
Therapeutic efficacy of a novel βIII/βIV-tubulin inhibitor (VERU-111) in pancreatic cancer.
Kashyap VK, Wang Q, Setua S, Nagesh PKB, Chauhan N, Kumari S, Chowdhury P, Miller DD, Yallapu MM, Li W, Jaggi M, Hafeez BB, Chauhan SC. Kashyap VK, et al. J Exp Clin Cancer Res. 2019 Jan 23;38(1):29. doi: 10.1186/s13046-018-1009-7. J Exp Clin Cancer Res. 2019. PMID: 30674344 Free PMC article.
Axonal regeneration. Systemic administration of epothilone B promotes axon regeneration after spinal cord injury.
Ruschel J, Hellal F, Flynn KC, Dupraz S, Elliott DA, Tedeschi A, Bates M, Sliwinski C, Brook G, Dobrindt K, Peitz M, Brüstle O, Norenberg MD, Blesch A, Weidner N, Bunge MB, Bixby JL, Bradke F. Ruschel J, et al. Science. 2015 Apr 17;348(6232):347-52. doi: 10.1126/science.aaa2958. Epub 2015 Mar 12. Science. 2015. PMID: 25765066 Free PMC article.
Drug-coated balloon for treatment of de-novo coronary artery lesions in patients with high bleeding risk (DEBUT): a single-blind, randomised, non-inferiority trial.
Rissanen TT, Uskela S, Eränen J, Mäntylä P, Olli A, Romppanen H, Siljander A, Pietilä M, Minkkinen MJ, Tervo J, Kärkkäinen JM; DEBUT trial investigators. Rissanen TT, et al. Lancet. 2019 Jul 20;394(10194):230-239. doi: 10.1016/S0140-6736(19)31126-2. Epub 2019 Jun 13. Lancet. 2019. PMID: 31204115 Clinical Trial.
Nab-paclitaxel plus S-1 as first-line followed by S-1 maintenance for advanced pancreatic adenocarcinoma: a single-arm phase II trial.
Zhang W, Du C, Sun Y, Yang L, Cui C, Jiang Z, Wang C, Wang J, Zhou A. Zhang W, et al. Cancer Chemother Pharmacol. 2018 Oct;82(4):655-660. doi: 10.1007/s00280-018-3650-4. Epub 2018 Jul 23. Cancer Chemother Pharmacol. 2018. PMID: 30054709 Free PMC article. Clinical Trial.
The effect of low-dose colchicine in patients with stable coronary artery disease: The LoDoCo2 trial rationale, design, and baseline characteristics.
Nidorf SM, Fiolet ATL, Eikelboom JW, Schut A, Opstal TSJ, Bax WA, Budgeon CA, Tijssen JGP, Mosterd A, Cornel JH, Thompson PL; LoDoCo2 Investigators. Nidorf SM, et al. Am Heart J. 2019 Dec;218:46-56. doi: 10.1016/j.ahj.2019.09.011. Epub 2019 Oct 20. Am Heart J. 2019. PMID: 31706144 Clinical Trial.
364 results
Jump to page
Feedback